YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)
HKD 12.66
(2.76%)
HKD 12.66
(2.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.67 Billion | 1.69 Billion | -662.51 Million | 1.29 Billion | 1.79 Billion | 715.39 Million |
| Net Income | 2.12 Billion | 76.6 Million | -587.64 Million | 839.45 Million | 1.91 Billion | 942.53 Million |
| Depreciation & Amortization | 391.27 Million | 377.35 Million | 259.81 Million | 122.72 Million | 86.18 Million | 61.08 Million |
| Deferred income taxes | - | - | - | - | 1.65 Billion | 327.83 Million |
| Stock-based compensation | 45.13 Million | - | - | - | 3.19 Million | 33.54 Million |
| Change in working capital | -1.4 Billion | -565.92 Million | -117.52 Million | 1.25 Billion | -1.65 Billion | -361.37 Million |
| Other non-cash items | 169.62 Million | 1.81 Billion | -217.15 Million | -920.77 Million | -210.48 Million | -288.23 Million |
| Investing Cash Flow | 554.56 Million | -1.12 Billion | -439.1 Million | -2.09 Billion | -1.71 Billion | -728.53 Million |
| Investments in PPE | -595.07 Million | -570.07 Million | -356.28 Million | -994.15 Million | -576.27 Million | -620.03 Million |
| Acquisitions | -12.6 Million | - | - | - | -78.15 Million | -352.98 Million |
| Investment purchases | -1.31 Billion | -290 Million | - | - | -267.16 Million | -330 Million |
| Sales/Maturities of investments | 3.9 Billion | - | - | - | 267.16 Million | 682.98 Million |
| Other Investing Activities | -1.49 Billion | -260.09 Million | -82.82 Million | -1.1 Billion | -1.05 Billion | -108.49 Million |
| Financing Cash Flow | -1.47 Billion | -787.02 Million | 187.47 Million | 64.63 Million | 2.1 Billion | -284.45 Million |
| Debt repayment | -1.33 Billion | -1.14 Billion | -157.67 Million | -1.25 Million | -311.66 Million | -10 Million |
| Dividends payments | - | - | - | -219.99 Million | -720.03 Million | -316.41 Million |
| Common Stock Repurchased | - | - | - | -136.91 Million | -245.95 Million | - |
| Common Stock Issuance | - | - | - | 138.16 Million | 557.62 Million | - |
| Other Financing Activities | -35.45 Million | 359.13 Million | 345.15 Million | 284.62 Million | 2.82 Billion | 41.96 Million |
| Accounts receivables | -1.41 Billion | -530.58 Million | -216.09 Million | 1.44 Billion | -1.62 Billion | -285.05 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -94.02 Million | -35.33 Million | 98.57 Million | -185.94 Million | -28.03 Million | -76.31 Million |
| Other working capital | 109.48 Million | - | - | - | - | - |
| Cash at beginning of period | 923.54 Million | 1.13 Billion | 2.04 Billion | 2.77 Billion | 593.74 Million | 887.18 Million |
| Cash at end of period | 1.67 Billion | 923.54 Million | 1.13 Billion | 2.04 Billion | 2.77 Billion | 593.74 Million |
| Capital Expenditure | -595.07 Million | -570.07 Million | -356.28 Million | -994.15 Million | -576.27 Million | -620.03 Million |
| Effect of forex changes on cash | -11 Thousand | -299 Thousand | 291 Thousand | -3.66 Million | 1.44 Million | 4.15 Million |
| Net cash flow / Change in cash | 750.87 Million | -207.57 Million | -913.84 Million | -734.17 Million | 2.18 Billion | -293.43 Million |
| Free Cash Flow | 1.07 Billion | 1.12 Billion | -1.01 Billion | 305.33 Million | 1.21 Billion | 95.35 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 684.73 Million | 963.12 Million | 2.12 Billion | 1.02 Billion | 76.6 Million | 109.4 Million |
| Depreciation & Amortization | 8.19 Billion | 198.36 Million | 391.27 Million | 192.9 Million | 377.35 Million | 203.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 45.13 Million | 45.13 Million | - | - | - |
| Change in working capital | - | -1.51 Billion | -1.4 Billion | - | -565.92 Million | -565.92 Million |
| Other non-cash items | -8.85 Billion | 733.71 Million | 169.62 Million | 22.39 Million | 1.81 Billion | 1.8 Billion |
| Investing Cash Flow | 150.55 Million | -663.23 Million | 554.56 Million | 1.21 Billion | -1.12 Billion | -643.23 Million |
| Investments in PPE | -401.89 Million | -128.13 Million | -595.07 Million | -215.58 Million | -570.07 Million | -280.42 Million |
| Acquisitions | - | - | -12.6 Million | - | - | - |
| Investment purchases | - | - | -1.31 Billion | - | -290 Million | - |
| Sales/Maturities of investments | - | - | 3.9 Billion | - | - | - |
| Other Investing Activities | 552.44 Million | -535.1 Million | -1.49 Billion | 1.43 Billion | -260.09 Million | -362.8 Million |
| Financing Cash Flow | -326.25 Million | -1.87 Billion | -1.47 Billion | 395.49 Million | -787.02 Million | -839.69 Million |
| Debt repayment | -275.09 Million | - | -1.33 Billion | -481.4 Million | -1.14 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -51.16 Million | -1.87 Billion | -35.45 Million | -85.91 Million | 359.13 Million | -839.69 Million |
| Accounts receivables | - | -1.41 Billion | -1.41 Billion | - | -530.58 Million | -530.58 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -94.02 Million | -94.02 Million | - | -35.33 Million | -35.33 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.67 Billion | 3.78 Billion | 923.54 Million | 923.54 Million | 1.13 Billion | 859.09 Million |
| Cash at end of period | 1.52 Billion | 3.78 Billion | 1.67 Billion | 3.78 Billion | 923.54 Million | 923.54 Million |
| Capital Expenditure | -401.89 Million | -128.13 Million | -595.07 Million | -215.58 Million | -570.07 Million | -280.42 Million |
| Effect of forex changes on cash | 1000.00 | 13 Thousand | -11 Thousand | -24 Thousand | -299 Thousand | -111 Thousand |
| Net cash flow / Change in cash | -151.29 Million | - | 750.87 Million | 2.85 Billion | -207.57 Million | 64.44 Million |
| Free Cash Flow | -377.48 Million | 300.28 Million | 1.07 Billion | 1.02 Billion | 1.12 Billion | 1.26 Billion |
SIE
AMFC
VRS
ASTA
ALGIR
ASLE